MELT3
LIVE

Serial Number

79250525

Owner

Invictus Biotechnology Pty Ltd

Attorney

Lindsay J. Hulley

Filing Date

Oct 19, 2018

Add to watchlist:

No watchlists yet
View on USPTO

MELT3 Trademark

Serial Number: 79250525 • Registration: 5929323

MELT3 is a trademark filed by Invictus Biotechnology Pty Ltd on October 19, 2018. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently registered and active.

Owner Contact Info

Invictus Biotechnology Pty Ltd (4 trademarks)

C/- ALM Williams Partners
MELBOURNE VIC 3004 , AU

Entity Type: 99

Trademark Details

Filing Date

October 19, 2018

Registration Date

December 10, 2019

Published for Opposition

September 24, 2019

Goods & Services

Dietary food supplements; dietary nutritional supplements; dietary protein supplements; dietary supplements; dietary supplement drinks for energy; food supplements in the nature of dietary supplements; herbal dietary supplements; plant compounds for use as dietary supplements for medicinal use; plant extracts in the nature of dietary supplements; protein dietary supplements; dietetic food supplements adapted for medical purposes; food supplements for medical purposes; medicated food supplements; medicated preparations for use as supplements for food; medicated supplements for food for humans; medicated supplements for foodstuffs for human consumption; medicinal food supplements; nutritional supplements; nutritional supplements for medical use; protein supplements for humans; nutritional supplements containing trace elements for foodstuffs for human consumption; vitamin preparations in the nature of food supplements; vitamin supplements; vitamin supplements for foodstuffs for human consumption; preparations of vitamins; stimulants made of vitamins for improving exercise performance; dietary supplemental drinks in the nature of vitamin drinks; vitamin preparations; vitamin preparations for human consumption; vitamin preparations in tablet form; vitamin tablets; vitamins; capsules sold empty for medicines; medicines for human purposes for the treatment of muscle injuries and disorders and sports related injuries and for increasing antioxidant levels, maintaining cholesterol and improving exercise, endurance, capacity, performance and cardiovascular health; medicines for human use for the treatment of muscle injuries and disorders and sports related injuries and for increasing antioxidant levels, maintaining cholesterol and improving exercise, endurance, capacity, performance and cardiovascular health; medicines for preventing muscle injuries and disorders and sports related injuries and cardiovascular ailments; medicines for treatment of the heart; medicines in tablet form for the treatment of muscle injuries and disorders and sports related injuries and for increasing antioxidant levels, maintaining cholesterol and improving exercise, endurance, capacity, performance and cardiovascular health; tablets for medicines, namely, drug delivery agents in the form of tablets that facilitate the delivery of pharmaceutical preparations; pharmaceutical preparations in the form of tablets for increasing antioxidant levels, maintaining cholesterol and improving exercise, endurance, capacity, performance and cardiovascular health; pharmaceutical tablets for muscle injuries and disorders and sports related injuries and for increasing antioxidant levels, maintaining cholesterol and improving exercise, endurance, capacity, performance and cardiovascular health; tablets being pharmaceuticals for increasing antioxidant levels, maintaining cholesterol and improving exercise, endurance, capacity, performance and cardiovascular health

Filing History

COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
Dec 10, 2024 REM3
FINAL DECISION TRANSACTION PROCESSED BY IB
Apr 10, 2020 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Mar 24, 2020 FICS
FINAL DISPOSITION PROCESSED
Mar 24, 2020 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Mar 10, 2020 FICR
REGISTERED-PRINCIPAL REGISTER
Dec 10, 2019 R.PR
NOTIFICATION PROCESSED BY IB
Oct 5, 2019 GPNX
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Sep 24, 2019 NPUB
PUBLISHED FOR OPPOSITION
Sep 24, 2019 PUBO
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Sep 18, 2019 OPNS
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Sep 18, 2019 OP2R
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Sep 4, 2019 NONP
ASSIGNED TO LIE
Aug 16, 2019 ALIE
APPROVED FOR PUB - PRINCIPAL REGISTER
Aug 9, 2019 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Aug 8, 2019 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Aug 8, 2019 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Aug 8, 2019 TROA
REFUSAL PROCESSED BY IB
Mar 2, 2019 RFNP
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Feb 12, 2019 RFCS
REFUSAL PROCESSED BY MPU
Feb 12, 2019 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Feb 5, 2019 RFCR
APPLICATION FILING RECEIPT MAILED
Feb 5, 2019 MAFR
NON-FINAL ACTION WRITTEN
Feb 4, 2019 CNRT
ASSIGNED TO EXAMINER
Feb 1, 2019 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Feb 1, 2019 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Jan 31, 2019 REPR